This inventor holds 1 USPTO granted patent and 9 published patent applications and 4 EPO patents. Top assignee: Meiragtx Gene Regulation Limited. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Dirk Grimm - Innovator in Gene Therapy
Introduction
Dirk Grimm is a notable inventor based in Heidelberg, Germany. He has made significant contributions to the field of gene therapy, particularly in the development of adeno-associated virus (AAV) vectors. Although he currently holds no granted patents, his work is influential in advancing therapeutic techniques for various disorders.
Latest Patent Applications
Dirk Grimm's latest patent applications include:
1. **AAV8 Capsid Variants with Enhanced Liver Targeting** - This application provides variant AAV8 capsids that exhibit altered capsid properties, such as improved transduction efficiency and specificity for the liver. It also includes nucleic acids encoding the variant AAV8 capsids, recombinant AAV vectors comprising these capsids, and methods for delivering gene products to treat liver-borne blood disorders.
2. **Use of a Synthetic AAV Capsid for Gene Therapy of Muscle and Central Nervous System Disorders** - This invention relates to the use of a recombinant porcine AAV vector with a peptide-modified capsid for gene therapy targeting muscle and central nervous system disorders, particularly genetic neuromuscular diseases.
Conclusion
Dirk Grimm's innovative work in gene therapy showcases his commitment to advancing medical science, despite not having any granted patents at this time. His contributions are paving the way for future developments in the treatment of complex disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile